The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma Prachi RanaJohn HaydekAnjana Pillai Hepatic Cancer (N Parikh, Section Editor) 28 November 2019 Pages: 371 - 382
Harms of Hepatocellular Carcinoma Surveillance Jan PetrasekAmit G. SingalNicole E. Rich Hepatic Cancer (N Parikh, Section Editor) 15 October 2019 Pages: 383 - 389
Liquid Biopsy for Hepatocellular Carcinoma Vincent L. ChenNeehar D. Parikh Hepatic Cancer (N Parikh, Section Editor) 29 October 2019 Pages: 390 - 399
Downstaging and Expanded Criteria Hepatocellular Carcinoma Liver Transplantation Phillipe AbreuAndre GorgenGonzalo Sapisochin Hepatic Cancer (N Parikh, Section Editor) 22 October 2019 Pages: 400 - 407
Screening Indications and Treatments for Cholangiocarcinoma Joseph C. AhnJu Dong Yang Hepatic Cancer (N Parikh, Section Editor) 31 October 2019 Pages: 408 - 416
Spectrum of Drug Induced Liver Injury Caused by Anabolic Androgenic Steroids Abuse Varun TakyarAndrew Stolz Drug-Induced Liver Injury (P Hayashi, Section Editor) 26 November 2019 Pages: 417 - 424
NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities Liyun YuanAni KardashianMonika Sarkar Fatty Liver Disease (V Ajmera, Section Editor) 18 November 2019 Pages: 425 - 432
Should We Screen High-Risk Populations for NAFLD? Cyrielle Caussy Fatty Liver Disease (V Ajmera, Section Editor) 08 November 2019 Pages: 433 - 443
Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease Albert DoYsabel C. Ilagan-YingWajahat Z. Mehal Fatty Liver Disease (V Ajmera, Section Editor) 21 November 2019 Pages: 444 - 454
Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease Omar T. AhmedAlina M. Allen Fatty Liver Disease (V Ajmera, Section Editor) 15 November 2019 Pages: 455 - 472
NAFLD Histology: a Critical Review and Comparison of Scoring Systems Rish K. Pai Fatty Liver Disease (V Ajmera, Section Editor) 04 November 2019 Pages: 473 - 481
HIV-Associated NAFLD: Disease Burden and Management Alyson KaplanJennifer C. Price Fatty Liver Disease (V Ajmera, Section Editor) 15 November 2019 Pages: 482 - 491
Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance Kee-Huat ChuahWah-Kheong Chan Fatty Liver Disease (V Ajmera, Section Editor) 11 November 2019 Pages: 492 - 502
Future Therapies for Functional Cure of Chronic HBV: Review of Investigational Drugs in Phase 1 and 2 Development Lung-Yi MakWai-Kay SetoMan-Fung Yuen Hepatitis B (J Lim, Section Editor) 01 November 2019 Pages: 503 - 511
Evidence-Based Approach to Stopping Oral Antiviral Therapy in Chronic HBV Maximilian WübboldingMarkus CornbergChristoph Höner zu Siederdissen Hepatitis B (J Lim, Section Editor) 11 November 2019 Pages: 512 - 521
Update in Drug Development for Chronic HBV/HDV Infection Dulce AlfaiateFrancesco Negro Hepatitis B (J Lim, Section Editor) 27 November 2019 Pages: 522 - 530
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma Byung-Han RhieuAmol K. NarangJeffrey Meyer Correction Open access 16 September 2019 Pages: 531 - 531